by Erik Stokstad
The U.K. House of Common's Science and Technology Committee announced today that it will conduct an inquiry into the British government's policies on licensing and funding of homeopathic remedies. Yesterday, it announced a similar inquiry into literary interventions and dyslexia.
A critic of the U.S. Food and Drug Administration's approach to approving drugs and medical devices will join the agency as a policy adviser. Peter Lurie was deputy director of the health research group for advocacy organization Public Citizen.
On 19 October, the National Human Genome Research Institute put researchers on notice about a nascent data sharing policy. It is intended to encourage broader accessibility to genomic data.
The Wellcome Trust is calling for journals to lower their subscription prices to reflect the income they get from open access fees. Meanwhile, the National Center for Atmospheric Research plans to launch a free repository next year of papers by its researchers.
Leave a comment
Thanks for your feedback. Please keep it polite and to the point.